Cara Therapeutics, Inc. Company Profile

17:59 EST 26th November 2014 | BioPortfolio


News Articles [27 Associated News Articles listed on BioPortfolio]

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q3 2014 Results - Earnings Call Transcript

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q2 2014 Results - Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2014 Results Earnings Conference Call August 07, 2014, 04:30 PM ET Executives Jesse Baumgartner - Stern Investor Relations, Inc. Derek Chalmers - President...

Cara Therapeutics doses first patient in Phase Ia/Ib trial of CR845 to treat acute, chronic pain

Enteris BioPharma, an industry leader in innovative oral dosage formulations, has announced that its development partner, Cara Therapeutics (CARA) has dosed the first subjects in a further Phase 1a/1b...

Inspiring Children's Book To Be Distributed Throughout Baltimore And Chicago

BALTIMORE, Nov. 19, 2014 /PRNewswire/ -- It's never too early to instill in children the importance of community service. "Cara Cookie Volunteers," the first children's book released by the Balti...

Cara Therapeutics begins Phase Ia/Ib trial of tablet formulation of oral pain drug CR845

US-based biopharmaceutical firm Cara Therapeutics has started dosing first subjects in a Phase Ia/Ib clinical trial of an oral tablet formulation of its peripherally-selective kappa opioid agonist, CR...

Cara Therapeutics begins Phase II trial of kappa opioid agonist to treat uremic pruritus

US-based biopharmaceutical firm Cara Therapeutics has dosed the first dialysis patients in a Phase II trial of an intravenous (IV) formulation of its peripherally selective kappa opioid agonist, CR845...

Cara management update

Cara Therapeutics Reports Second Quarter 2014 Financial Results

SHELTON, Conn., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevia...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Label-free chemiluminescent aptasensor for platelet-derived growth factor detection based on exonuclease-assisted cascade autocatalytic recycling amplification.

Here an exonuclease III (Exo III)-assisted cascade autocatalytic recycling amplification (Exo-CARA) strategy is proposed for label-free chemiluminescent (CL) detection of platelet-derived growth facto...

Inference of Expanded Lrp-Like Feast/Famine Transcription Factor Targets in a Non-Model Organism Using Protein Structure-Based Prediction.

Widespread microbial genome sequencing presents an opportunity to understand the gene regulatory networks of non-model organisms. This requires knowledge of the binding sites for transcription factors...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Protecting the 'Hood Against Tobacco

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...

Companies [4 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME

Instituto de Cirugía Maxilofacial e Implantología

Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record